VCYT FY 2012 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+339.6% YoY

Gross Profit

$4M34.8% margin

Operating Income

-$19M-162.8% margin

Net Income

-$19M-160.4% margin

EPS (Diluted)

$-1.31

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$9M

Stock-Based Comp.

$934,000

Balance Sheet

Total Assets

$19M

Total Liabilities

$14M

Stockholders' Equity

$5M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$3M	+339.6%
Gross Profit	$4M	-$280,000	+1544.3%
Operating Income	-$19M	-$15M	-24.0%
Net Income	-$19M	-$14M	-29.1%